Steve G Papermaster, Nano chairman and CEO, has 30 years of experience as a career technology entrepreneur, noted author, global speaker, and public policy expert. Having formerly served as an advisor to President George W. Bush, Steve G Papermaster is now involved with several publicly traded and private companies. This article will look at nanotechnology and the potential of AI to aid its advancement.

Despite the immense hype surrounding artificial intelligence and nanotechnology today, in many ways, they are the least understood of all emerging technologies. While unusual case uses of both technologies grab the headlines, such as use of AI to ‘fake your own voice’, the reality is that both nanotech and AI are already part of everyday life and are being implemented in a variety of ways. Increasingly, these technologies are converging, presenting huge potential in the medical world.

One of the clearest examples of how AI and nanotechnology can work together is atomic force microscopy (AFM), a technique used for imaging objects at the nanoscale. This is a useful capability in many industries, from quality assurance when building microchips to looking at cells within the human body. However, AFM is not without its challenges, as at this scale even the materials that make up the microscope itself have an impact on data.

AI helps to reduce noisy signals through a process of functional recognition imaging, using principal component analysis and artificial neural networks to streamline the input data in the neural network.

When combined, nanotechnology and AI show the potential to transform the medical industry to an extent never witnessed before through the development of advanced clinical support tools based on machine learning to increase accuracy and efficiency. This combination of nanotechnology and AI shows particular potential in the realm of anesthesia, a particularly complex medical specialty.

Nano is a health technology company founded by Steve G Papermaster to bring the same innovation to the health sector that technology has delivered to other industries in recent history.

Despite having a deep respect and admiration for the history of vaccine and drug development, Nano is not limited by conventional distribution constraints. While many medications and vaccines will continue to be delivered by traditional pills and syringes, Nano was created with the vision of widening that range, developing delivery mechanisms such as nasal sprays and topical creams to make administration more comfortable and convenient.

Based in Austin, Texas, Nano seeks to address health threats through a multi-layered set of solutions, ushering in a new era in persistent, proactive health protection.